Clinical trials
Colonic Neoplasms trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 19 |
| Recruiting | 10 |
| Completed | 8 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| RenJi Hospital | 5 |
| Peking Union Medical College Hospital | 4 |
| Carponovum AB | 2 |
| National Cancer Center, China | 2 |
| Peking University Cancer Hospital & Institute | 2 |
| Ruijin Hospital | 2 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| Fudan University | 1 |
| Guo ShiWei | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 45 |
| Stomach Neoplasms | 11 |
| Rectal Neoplasms | 9 |
| Esophageal Neoplasms | 7 |
| Hypoxia | 5 |
| Colonic Polyps | 4 |
| Colorectal Neoplasms | 4 |
| Liver Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Disease | 3 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.